The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Information, Progression-Free Survival in Non-Hematologic Malignancies, for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 186KB)